Home
RMD
RMD News

Latest ResMed Inc. (RMD) News on June 21, 2025

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

StockStory

3 days ago

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

Argus Research

11 days ago

RMD: Raising target price to $265.00

Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue?

Zacks

15 days ago

Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue?

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

StockStory

16 days ago

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?

Zacks

17 days ago

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

StockStory

18 days ago

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down

StockStory

19 days ago

2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down

Newsfile

22 days ago

Sienna Resources Inc. Announces Private Placement

Energy Global

22 days ago

European Energy completes sale of Polish wind portfolio to Enea Group

Newsfile

22 days ago

Carbone Restaurant Group is a GOLD Sponsor at the Centurion One Capital 6th Annual LA Summit

Newsfile

22 days ago

Max Resource Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

First Foundation Bank review (2025): Personal and business banking with competitive online rates

Yahoo Personal Finance

22 days ago

First Foundation Bank review (2025): Personal and business banking with competitive online rates

Investing.com

22 days ago

Airbnb shares dip as Truist cuts stock to Sell on weak summer trends, valuation

Report: Slower economy doesn't dim downtown Austin's dynamism

Austin American-Statesman

22 days ago

Report: Slower economy doesn't dim downtown Austin's dynamism

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

GuruFocus.com

22 days ago

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?

Zacks

a month ago

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

Zacks

a month ago

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

1 Surging Stock with Exciting Potential and 2 to Avoid

StockStory

a month ago

1 Surging Stock with Exciting Potential and 2 to Avoid

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed

TipRanks

a month ago

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed

1 Unpopular Stock that Should Get More Attention and 2 to Brush Off

StockStory

a month ago

1 Unpopular Stock that Should Get More Attention and 2 to Brush Off

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

a month ago

Here's Why ResMed (RMD) is a Strong Growth Stock

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Motley Fool

a month ago

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

GlobeNewswire

a month ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

StockStory

a month ago

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

Argus Research

a month ago

RMD: Rating increased to a BUY

Argus Research

a month ago

RMD: Raising target price to $254.00

3 Profitable Stocks to Consider Right Now

StockStory

2 months ago

3 Profitable Stocks to Consider Right Now

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

Simply Wall St.

2 months ago

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

This ResMed Insider Reduced Their Stake By 72%

Simply Wall St.

2 months ago

This ResMed Insider Reduced Their Stake By 72%

Resmed acquires independent diagnostic testing facility VirtuOx

Medical Device Network

2 months ago

Resmed acquires independent diagnostic testing facility VirtuOx

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

MedTech Dive

2 months ago

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

MT Newswires

2 months ago

ResMed Buys VirtuOx for Undisclosed sum

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Resmed Acquires VirtuOx

GlobeNewswire

2 months ago

Resmed Acquires VirtuOx

Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

Insider Monkey

2 months ago

Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

iRhythm Earnings: What To Look For From IRTC

StockStory

2 months ago

iRhythm Earnings: What To Look For From IRTC

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

StockStory

2 months ago

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

Zacks

2 months ago

MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks

2 months ago

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

ResMed (NYSE:RMD) Reports Strong Q3 Earnings Growth and Declares US$0.53 Dividend

Simply Wall St.

2 months ago

ResMed (NYSE:RMD) Reports Strong Q3 Earnings Growth and Declares US$0.53 Dividend

MT Newswires

2 months ago

KeyBanc Adjusts Price Target on ResMed to $274 From $269, Maintains Overweight Rating

MT Newswires

2 months ago

Jefferies Adjusts Price Target on ResMed to $245 From $270, Maintains Hold Rating

MT Newswires

2 months ago

Piper Sandler Adjusts Price Target on ResMed to $248 From $260, Maintains Neutral Rating

MT Newswires

2 months ago

Morgan Stanley Adjusts Price Target on ResMed to $286 From $280, Maintains Overweight Rating

MT Newswires

2 months ago

JPMorgan Adjusts Price Target on ResMed to $290 From $286, Maintains Overweight Rating

MT Newswires

2 months ago

Mizuho Adjusts Price Target on ResMed to $250 From $265, Maintains Outperform Rating

MT Newswires

2 months ago

Wolfe Research Adjusts Price Target on ResMed to $200 From $195, Maintains Underperform Rating

Thomson Reuters StreetEvents

2 months ago

Q3 2025 Resmed Inc Earnings Call

Morningstar Research

2 months ago

Analyst Report: ResMed Inc.

MT Newswires

2 months ago

RBC Raises Price Target on ResMed to $255 From $247, Keeps Sector Perform Rating

ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

Zacks

2 months ago

ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

ResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

2 months ago

ResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Here's What Key Metrics Tell Us About ResMed (RMD) Q3 Earnings

Zacks

2 months ago

Here's What Key Metrics Tell Us About ResMed (RMD) Q3 Earnings

ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

Zacks

2 months ago

ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

StockStory

2 months ago

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

StockStory

2 months ago

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

Resmed Names Salli Schwartz as Chief Investor Relations Officer

GlobeNewswire

2 months ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

Zacks

2 months ago

Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

MT Newswires

2 months ago

KeyBanc Adjusts ResMed Price Target to $269 From $280, Maintains Overweight Rating

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

Zacks

2 months ago

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

2 months ago

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

MT Newswires

2 months ago

Mizuho Securities Adjusts ResMed Price Target to $265 From $280, Maintains Outperform Rating

Argus Research

2 months ago

RMD: Rating decreased to a HOLD

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

2 months ago

Here's Why ResMed (RMD) is a Strong Growth Stock

MT Newswires

2 months ago

Baird Cuts Price Target on ResMed to $252 From $286, Maintains Outperform Rating

MT Newswires

2 months ago

ResMed's Fiscal Q3 Likely to Meet Consensus Estimates; Faces Supply Chain Risks, UBS Says

Morningstar Research

2 months ago

Analyst Report: ResMed Inc.

Argus Research

2 months ago

RMD: Lowering target price to $241.00

Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?

Zacks

2 months ago

Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory

2 months ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US

Simply Wall St.

3 months ago

ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US

ResMed Inc. (RMD): A Bull Case Theory

Insider Monkey

3 months ago

ResMed Inc. (RMD): A Bull Case Theory

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

GlobeNewswire

3 months ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock

Insider Monkey

3 months ago

Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

GlobeNewswire

3 months ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Argus Research

3 months ago

RMD: Rating increased to a BUY

Morgan Stanley Sees Near-Term Rally Ahead — Here Are 2 Stocks to Bet on It

TipRanks

3 months ago

Morgan Stanley Sees Near-Term Rally Ahead — Here Are 2 Stocks to Bet on It

Jim Cramer On ResMed Inc. (RMD) – “I’m With Mick! ResMed’s Doing Quite Well”

Insider Monkey

3 months ago

Jim Cramer On ResMed Inc. (RMD) – “I’m With Mick! ResMed’s Doing Quite Well”

Argus Research

3 months ago

RMD: Raising target price to $232.00

ResMed initiated with an Overweight at Morgan Stanley

TipRanks

3 months ago

ResMed initiated with an Overweight at Morgan Stanley

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

GlobeNewswire

3 months ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

New Product Launches Benefit GMED Stock Amid Macro Issues

Zacks

3 months ago

New Product Launches Benefit GMED Stock Amid Macro Issues

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

3 months ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic

Zacks

3 months ago

The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic

NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus

Zacks

3 months ago

NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus

Zacks

3 months ago

RMD Stock Likely to Benefit From the New Brand Evolution Strategy

MT Newswires

3 months ago

Resmed Consolidating Brands, Product Lines Under Single Name

GlobeNewswire

3 months ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

StockStory

3 months ago

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

ResMed Among Top Stocks For Recent And Long-Term Profit Growth

Investor's Business Daily

3 months ago

ResMed Among Top Stocks For Recent And Long-Term Profit Growth

VEEV Stock Gains Following Latest Availability of HCP Access Data

Zacks

3 months ago

VEEV Stock Gains Following Latest Availability of HCP Access Data

Is it Worth Adding ResMed Stock to Your Portfolio Now?

Zacks

4 months ago

Is it Worth Adding ResMed Stock to Your Portfolio Now?

Zacks.com featured highlights include Taiwan, Tapestry, ABM Industries, Vertiv and ResMed

Zacks

4 months ago

Zacks.com featured highlights include Taiwan, Tapestry, ABM Industries, Vertiv and ResMed

5 Best Dividend Growth Stocks to Buy Amid Trade War Fears

Zacks

4 months ago

5 Best Dividend Growth Stocks to Buy Amid Trade War Fears

ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?

Zacks

4 months ago

ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?

MT Newswires

4 months ago

Stifel Adjusts Price Target on ResMed to $240 From $250, Maintains Hold Rating

Argus Research

4 months ago

RMD: Lowering target price to $243.00

VEEV Stock Falls Despite Latest Announcement to Enable AI Innovation

Zacks

4 months ago

VEEV Stock Falls Despite Latest Announcement to Enable AI Innovation

2 Reasons to Like RMD and 1 to Stay Skeptical

StockStory

4 months ago

2 Reasons to Like RMD and 1 to Stay Skeptical

Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up

Zacks

4 months ago

Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up

Share on Social Networks: